Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist.
Castillo GM, Yao Y, Guerra RE, Jiang H, Nishimoto-Ashfield A, Lyubimov AV, Alfaro JF, Striker KA, Buynov N, Schwabl P, Bolotin EM.
Castillo GM, et al. Among authors: bolotin em.
Biomed Pharmacother. 2024 Feb;171:116068. doi: 10.1016/j.biopha.2023.116068. Epub 2024 Jan 4.
Biomed Pharmacother. 2024.
PMID: 38176129
Free PMC article.